Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.9257
+0.0366 (4.12%)
At close: Jan 16, 2026, 4:00 PM EST
0.9400
+0.0143 (1.54%)
After-hours: Jan 16, 2026, 6:27 PM EST
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $21.38 million as of January 16, 2026. Its market cap has increased by 435.83% in one year.
Market Cap
21.38M
Enterprise Value
17.25M
1-Year Change
435.83%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $21.38M, a decrease of -67.26%. That is a compound annual growth rate of -22.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 21.38M | -28.24% |
| Dec 31, 2025 | 29.79M | 646.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |